Focus Partners Advisor Solutions LLC purchased a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 9,011 shares of the financial services provider's stock, valued at approximately $724,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Csenge Advisory Group lifted its holdings in shares of MetLife by 1.0% in the first quarter. Csenge Advisory Group now owns 13,647 shares of the financial services provider's stock worth $1,096,000 after buying an additional 131 shares in the last quarter. Delta Investment Management LLC lifted its holdings in shares of MetLife by 0.9% in the first quarter. Delta Investment Management LLC now owns 14,265 shares of the financial services provider's stock worth $1,145,000 after buying an additional 133 shares in the last quarter. Stock Yards Bank & Trust Co. lifted its holdings in shares of MetLife by 2.5% in the first quarter. Stock Yards Bank & Trust Co. now owns 6,463 shares of the financial services provider's stock worth $519,000 after buying an additional 159 shares in the last quarter. Unigestion Holding SA lifted its holdings in shares of MetLife by 0.7% in the first quarter. Unigestion Holding SA now owns 23,661 shares of the financial services provider's stock worth $1,900,000 after buying an additional 165 shares in the last quarter. Finally, Davis R M Inc. lifted its holdings in shares of MetLife by 5.3% in the first quarter. Davis R M Inc. now owns 3,315 shares of the financial services provider's stock worth $266,000 after buying an additional 167 shares in the last quarter. 94.99% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently issued reports on MET shares. Barclays increased their price target on shares of MetLife from $88.00 to $94.00 and gave the stock an "overweight" rating in a report on Monday, July 7th. Keefe, Bruyette & Woods lowered their price target on shares of MetLife from $94.00 to $92.00 and set an "outperform" rating on the stock in a report on Monday, August 11th. JPMorgan Chase & Co. raised their target price on shares of MetLife from $86.00 to $95.00 and gave the company an "overweight" rating in a research note on Tuesday, July 8th. Wall Street Zen downgraded shares of MetLife from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Finally, Wells Fargo & Company reaffirmed an "overweight" rating and issued a $97.00 target price (up from $94.00) on shares of MetLife in a research note on Thursday, July 10th. Ten analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $95.60.
Get Our Latest Analysis on MET
MetLife Price Performance
Shares of MET stock traded down $2.24 during trading hours on Friday, hitting $79.51. 4,830,111 shares of the company's stock were exchanged, compared to its average volume of 2,820,923. The company has a market capitalization of $52.87 billion, a PE ratio of 13.48, a PEG ratio of 0.71 and a beta of 0.87. MetLife, Inc. has a 12-month low of $65.21 and a 12-month high of $89.05. The business's 50 day simple moving average is $78.26 and its 200-day simple moving average is $78.36. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.57.
MetLife (NYSE:MET - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing the consensus estimate of $2.32 by ($0.30). The business had revenue of $17.34 billion for the quarter, compared to analysts' expectations of $18.58 billion. MetLife had a return on equity of 19.88% and a net margin of 5.83%.The company's revenue was down 2.7% compared to the same quarter last year. During the same period last year, the business posted $2.28 earnings per share. On average, equities research analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current year.
MetLife Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 5th will be paid a dividend of $0.5675 per share. The ex-dividend date of this dividend is Tuesday, August 5th. This represents a $2.27 annualized dividend and a dividend yield of 2.9%. MetLife's dividend payout ratio (DPR) is 38.47%.
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.